Abstract & case submission
Abstract & case submission is an important part of the EHA-SWG Scientific Meeting “the Blood and the Child - New Insights in Pediatric Benign Hematology”. As a participant, you will have the opportunity to submit an abstract or case for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers. Abstracts & cases can be submitted until the deadline of March 6, 2022 (23:59 CET).
A selection of abstracts will be eligible for acceptance during the meeting, the presentation format will be in the form of oral presentations or poster presentations. Presenting authors will receive a separate invitation after the allocation notification has been sent to all abstract submitters. The corresponding authors will be informed of the allocation results as soon as possible.
You can submit an abstract or case on one of the following topics:
- Coagulation defects
- Gene therapy and gene editing in benign hematology
- Inherited and acquired bone marrow failures
- Iron metabolism
- NGS in diagnosis
- Red cell defects
- Thalassemias and SCD
- Transfusion therapy
The abstracts will be reviewed and allocated by the Scientific Program Committee. Submitting authors will be informed about the allocation by March 15, 2022.
Please note that the submission of an abstract constitutes a formal commitment by the author to attend the meeting (if the abstract is accepted) and if required present the abstract as an oral presentation or poster presentation in the session and the time assigned by the Scientific Program Committee.
We therefore recommend that presenting authors of abstracts register for the meeting simultaneously with abstract submission. For more information about registration and to register, click here.
Should you have any questions, please contact email@example.com.